ISNTD d³ 2022 addresses the current gaps and collaboration opportunities across tropical diseases and diseases of poverty to accelerate drug discovery & development, vaccine R&D and uptake, and diagnostics and surveillance opportunities.
Disease focus: sleeping sickness, de-risking discovery through partnerships and driving sustainability through access
Date: Wednesday, 29 June 2022
Time: 14.00-16.00 UTC
- Philippe Neau, Head of Neglected Tropical Diseases Program at Global Health Sanofi
- Florent Mbo, Access Leader and Regional HAT Platform Coordinator, DNDi, DRC
- François Bompart, Access Committee Chair, DNDi